CLIAC: Clinical Laboratory Improvement Advisory Committee

At a glance

The Clinical Laboratory Improvement Advisory Committee (CLIAC) provides guidance to the Department of Health and Human Services (HHS). The advice and guidance CLIAC provides to HHS pertains to general issues related to improvement in clinical laboratory quality and laboratory medicine practice.

About

The Clinical Laboratory Improvement Advisory Committee (CLIAC) is managed by the Centers for Disease Control and Prevention (CDC). CLIAC provides scientific and technical advice to the Department of Health and Human Services (HHS).

Impact

CLIAC advises HHS on improving clinical laboratory quality and laboratory medicine practice. The Committee also offers guidance on revising Clinical Laboratory Improvement Amendments (CLIA) standards.

See Also: Federal Advisory Committee Database CLIAC page

Members

The Committee has a consumer representative and has diverse membership across:

  • Laboratory specialties.
  • Professional roles: laboratory management, technical, physicians, nurses.
  • Practice settings: academic, clinical, public health.

The clinical and anatomic pathology laboratory specialties represented include:

  • Microbiology
  • Immunology
  • Chemistry
  • Hematology
  • Immunohematology
  • Cytopathology
  • Histopathology
  • Genetic testing
  • Informatics

The Committee also includes three ex officio members from the federal agencies that oversee the CLIA program, specifically the:

A nonvoting liaison representing the laboratory industry participates on the Committee.

Who to contact

Centers for Disease Control and Prevention (CDC)

Center for Laboratory Systems and Response (CLSR)

Division of Laboratory Systems (DLS)

1600 Clifton Road

Mailstop V24-3

Atlanta, GA 30329-4018

USA

Email: CLIAC@cdc.gov

Print
Content Source:
Division of Laboratory Systems (DLS)